<- Go home

Added to YB: 2026-10-09

Pitch date: 2026-10-06

SRT3.DE [neutral]

Sartorius Aktiengesellschaft

+0.97%

current return

Author Info

Lux Opes Research covers European companies. Lots of them. Sign up for the newsletter.

Company Info

Sartorius Aktiengesellschaft provides bioprocess solutions, and lab products and services worldwide. The company offers analytical solutions, such as biolayer interferometry systems, high-throughput screening by cytometry systems, process analytical technology and data analytics, cell selection and retrieval, live-cell imaging and analysis systems, and surface plasmon resonance systems; cell culture solutions, including bioreactors and fermenters, cell culture reagents, supplements and matrices, nucleic acid and delivery solutions, cell culture media, and cell lines and buffers; and fluid management products.

Market Cap

EUR 15.8B

Pitch Price

EUR 207.00

Price Target

N/A

Dividend

0.29%

EV/EBITDA

21.30

P/E

N/A

EV/Sales

5.79

Sector

Life Sciences Tools and Services

Category

growth

Show full summary:
Sartorius AG (SRT3 Germany): Single-use adoption has room to run

SRT3.DE (update): Sartorius has a long growth runway as biopharma shifts toward smaller, flexible production systems. Management expects the Bioprocess Solutions market to grow 8-10% annually, while single-use penetration remains below 20% in commercial production versus above 85% in clinical development. Its integrated equipment and consumables portfolio can capture new capacity spending and recurring demand as adoption expands.

Read full article (2 min)